Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Accumulated Expenses (2018 - 2025)

Health Catalyst's Accumulated Expenses history spans 8 years, with the latest figure at $18.7 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 29.02% year-over-year to $18.7 million; the TTM value through Dec 2025 reached $18.7 million, down 29.02%, while the annual FY2025 figure was $18.7 million, 29.02% down from the prior year.
  • Accumulated Expenses reached $18.7 million in Q4 2025 per HCAT's latest filing, roughly flat from $18.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $26.3 million in Q4 2024 to a low of $5.9 million in Q2 2025.
  • Average Accumulated Expenses over 5 years is $15.2 million, with a median of $14.1 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: soared 240.15% in 2021, then plummeted 59.35% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $23.7 million in 2021, then plummeted by 48.66% to $12.2 million in 2022, then surged by 91.15% to $23.3 million in 2023, then grew by 13.13% to $26.3 million in 2024, then fell by 29.02% to $18.7 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Accumulated Expenses are $18.7 million (Q4 2025), $18.6 million (Q3 2025), and $5.9 million (Q2 2025).